![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 20, 17052-17057, May 18, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Pathology, Washington University School of
Medicine, St. Louis, Missouri 63110
Recognition of carbohydrates on
glycosylated molecules typically requires multivalent interactions with
receptors. Monovalent forms of terminal saccharides engaged by the
receptor binding sites typically display weak affinities in the
mM range and poor specificity. In contrast,
multivalent forms of the same saccharides are bound with strong
affinity (10
The Mannose/N-Acetylgalactosamine-4-SO4
Receptor Displays Greater Specificity for Multivalent than Monovalent
Ligands*
7-10
9 M) and
significantly greater specificity. Although multivalency can readily
account for increased affinity, the molecular basis for enhanced
specificity is not well understood. We have examined the specificity of
the cysteine-rich domain of the mannose/GalNAc-4-SO4 receptor using monovalent and multivalent forms of the trisaccharide GalNAc
1,4GlcNAc
1,2Man
(GGnM) sulfated at either the C4
(S4GGnM) or C3 (S3GGnM) hydroxyl of the terminal GalNAc. Monovalent
S4GGnM and S3GGnM have Ki values of 25.8 and 16.2 µM, respectively. Multivalent conjugates of the same
GalNAc-4-SO4- and GalNAc-3-SO4-bearing trisaccharides (6.7 mol of trisaccharide/mol of bovine serum albumin) have Ki values of 0.013 and 0.170 µM,
respectively. The 2000-fold versus 95-fold change in
affinity seen for the multivalent forms of these 4-sulfated and
3-sulfated trisaccharides reflects a difference in the impact of
conformational entropy. A large fraction of the
SO4-3-GalNAc structures exists in a form that is not
favorable for binding to the Cys-rich domain. This reduces the
effective concentration of SO4-3-GalNAc as compared with
SO4-4-GalNAc under the same conditions and results in a
markedly lower association rate. This difference in association rate
accounts for the 12-fold difference in the rate of clearance from the
blood seen with S4GGnM-BSA and S3GGnM-BSA in
vivo.
*
This work was supported by National Institutes of Health
Grants R37-CA21923 and R01-DK41738.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 314-362-8730;
Fax: 314-362-8888; E-mail: Baenziger@Pathology.WUSTL.EDU.
This article has been cited by other articles:
![]() |
D. Fiete, Y. Mi, E. L. Oats, M. C. Beranek, and J. U. Baenziger N-Linked Oligosaccharides on the Low Density Lipoprotein Receptor Homolog SorLA/LR11 Are Modified with Terminal GalNAc-4-SO4 in Kidney and Brain J. Biol. Chem., January 19, 2007; 282(3): 1873 - 1881. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F. Medzihradszky, D. I.R. Spencer, S. K. Sharma, J. Bhatia, R. B. Pedley, D. A. Read, R. H.J. Begent, and K. A. Chester Glycoforms obtained by expression in Pichia pastoris improve cancer targeting potential of a recombinant antibody-enzyme fusion protein Glycobiology, January 1, 2004; 14(1): 27 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. Park, S. M. Manzella, and J. U. Baenziger Rapid Clearance of Sialylated Glycoproteins by the Asialoglycoprotein Receptor J. Biol. Chem., February 7, 2003; 278(7): 4597 - 4602. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Woodworth, D. Fiete, and J. U. Baenziger Spatial and Temporal Regulation of Tenascin-R Glycosylation in the Cerebellum J. Biol. Chem., December 20, 2002; 277(52): 50941 - 50947. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Strott Sulfonation and Molecular Action Endocr. Rev., October 1, 2002; 23(5): 703 - 732. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |